SITAGLIPTIN Metform Mepha retard 100/1000mg 30 pce
7680690330057
CH-69033
A10BD07
07.06.2.
Reimbursement limitations:
JANUMET3
Pour le traitement des patients diabétiques de type 2 qui ne peuvent pas être suffisamment …
1 / 3
google
Details
- Product number
- 6903303
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- sitagliptinum 100 mg ut sitagliptini hydrochloridum monohydricum, metformini hydrochloridum 1000 mg, hypromellosum, magnesii stearas, calcii hydrogenophosphas, cellulosum microcristallinum, natrii stearylis fumaras, carmellosum natricum conexum, Überzug: poly(alcohol vinylicus), E 171, macrogolum 4000, talcum, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium 1.427 mg.
Articles (1)
Sitagliptin-Metformin-Mepha retard 100/1000 mg, Tabletten mit veränderter Wirkstofffreisetzung
Tabletten mit veränderter Wirkstofffreisetzung
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
1000.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
1.427 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 33.10
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/12/2023
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 69033
- Drug name
- Sitagliptin-Metformin-Mepha retard, Tabletten mit veränderter Wirkstofffreisetzung
- Galenic form
- TABWF
- ATC Code
- A10BD07
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 18/04/2023
- Authorization expiration date
- 17/04/2028
- IT number
- 07.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SITAGLIPTIN Metform Mepha retard 100/1000mg 30 pce
- Description (DE)
- SITAGLIPTIN Metform Mepha retard 100/1000mg 30 Stk
- Market launch
- 18/04/2023
- Narcotic (BTM)
- No